Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results

Key Points

• Q2 revenue rose 45% year over year to $3.9 million, with system sales increasing 50% to 12 units, although revenue fell short of analysts’ $4.13 million estimate. EPS matched expectations at a loss of $0.09.
• Gross margin remained solid at 50.7%, and first-half cash burn improved 9% year over year to $16.6 million. Management reiterated 2026 guidance for $20 million–$22 million in revenue and said its cash runway extends into 2028.
• Hyperfine remains loss-making, posting a $9.3 million quarterly net loss; its cash position was partly supported by $10.6 million raised through an ATM program, which could dilute shareholders. Analysts have a consensus “Hold” rating and an average price target of $1.78.

Hyperfine (NASDAQ:HYPR - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.09) EPS for the quarter, hitting analysts' consensus estimates of ($0.09), FiscalAI reports. Hyperfine had a negative net margin of 226.88% and a negative return on equity of 98.83%. The business had revenue of $3.90 million during the quarter, compared to analysts' expectations of $4.13 million.

Here are the key takeaways from Hyperfine's conference call:

• Revenue rose 45% year over year to $3.9 million in Q2, while system sales increased 50% to 12 units; first-half revenue reached $7.8 million.
• Gross margin remained above 50% for the fourth consecutive quarter at 50.7%, while first-half cash burn improved approximately 9% year over year to $16.6 million.
• Management reiterated 2026 revenue guidance of $20 million to $22 million, gross margin of 50% to 55%, cash burn of $26 million to $28 million, and cash runway extending into 2028.
• Growth is broadening across hospitals and IDNs, neurology offices, and international markets; the company cited initial large-IDN adoption, more than a dozen office placements, and first European Model 2 sales.
• Hyperfine remains loss-making, reporting a $9.3 million quarterly net loss, and its stronger cash position partly reflects $10.6 million raised through its ATM program, which may create shareholder dilution.

Hyperfine Trading Up 0.2%

Shares of Hyperfine stock traded up $0.00 on Thursday, hitting $0.98. 373,535 shares of the company traded hands, compared to its average volume of 769,529. The company has a current ratio of 5.52, a quick ratio of 4.90 and a debt-to-equity ratio of 0.38. The company has a market cap of $97.48 million, a PE ratio of -2.40 and a beta of 1.42. The stock's 50 day moving average price is $1.24 and its 200-day moving average price is $1.25. Hyperfine has a 52 week low of $0.85 and a 52 week high of $2.22.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. State Street Corp lifted its holdings in shares of Hyperfine by 6.1% in the 4th quarter. State Street Corp now owns 265,195 shares of the company's stock worth $260,000 after buying an additional 15,200 shares during the period. Renaissance Technologies LLC increased its stake in shares of Hyperfine by 674.4% during the fourth quarter. Renaissance Technologies LLC now owns 364,743 shares of the company's stock valued at $357,000 after buying an additional 317,645 shares during the period. Geode Capital Management LLC raised its holdings in shares of Hyperfine by 21.4% in the fourth quarter. Geode Capital Management LLC now owns 815,986 shares of the company's stock valued at $799,000 after acquiring an additional 143,975 shares in the last quarter. Vanguard Group Inc. lifted its stake in Hyperfine by 5.7% in the third quarter. Vanguard Group Inc. now owns 3,511,972 shares of the company's stock worth $5,092,000 after acquiring an additional 190,136 shares during the period. Finally, XTX Topco Ltd lifted its stake in Hyperfine by 47.9% in the fourth quarter. XTX Topco Ltd now owns 80,735 shares of the company's stock worth $79,000 after acquiring an additional 26,165 shares during the period. 15.03% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on HYPR. BTIG Research initiated coverage on shares of Hyperfine in a report on Wednesday, April 29th. They issued a "buy" rating and a $2.00 price target for the company. B. Riley Financial reissued a "buy" rating on shares of Hyperfine in a research note on Wednesday, May 13th. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Hyperfine in a research note on Friday, July 17th. Three analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $1.78.

Hyperfine Company Profile

Hyperfine, Inc NASDAQ: HYPR is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company's flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient's bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source